Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “First Wave Bio, Inc.”

11 pharma patents match "First Wave Bio, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "First Wave Bio, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “First Wave Bio, Inc.” · 30,257 patents in full index Clear search

  1. US 11793777

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  2. US 11744812

    Methods of treatment

    First Wave Bio, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  3. US 11564896

    Methods of treatment

    First Wave Bio, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  4. US 10980756

    Methods of treatment

    First Wave Bio, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  5. US 10912746

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  6. US 10905666

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  7. US 10849867

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  8. US 10799468

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  9. US 10772854

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  10. US 10744103

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  11. US 10292951

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.